Diabetes Therapy to Improve BMI and Lung Function in CF

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
To recruit 150 adult patients with cystic fibrosis related diabetes (CFRD) without fasting hyperglycemia for a multi-center, twelve month, placebo-controlled intervention trial testing the ability of insulin or repaglinide to improve body mass index (BMI) and stabilize pulmonary function in cystic fibrosis (CF).
Epistemonikos ID: 8edda457e5652d6a2d9966eaa1b5e7f6cdc661ef
First added on: May 04, 2024